SUBSCRIBE
SUBSCRIBE

C4 Therapeutics

NEWS
Booming C4 Therapeutics to Move Out of Pricey Kendall Square Next Year
Business
What You Need to Know About C4 Therapeutics
January 3, 2017
 · 
6 min read
Load More
AWARDS
  • NextGen Class of 2017
JOBS
IN THE PRESS
Press Releases
C4 Therapeutics Announces Delivery of Second Development Candidate to Biogen
September 10, 2024
 · 
4 min read
Press Releases
C4 Therapeutics to Present Preliminary CFT1946 Monotherapy Phase 1 Clinical Data at the European Society for Medical Oncology (ESMO) Congress 2024
September 9, 2024
 · 
4 min read
Press Releases
C4 Therapeutics Appoints Veteran Biotechnology Leader Stephen Fawell, Ph.D. to Board of Directors
September 3, 2024
 · 
5 min read
Business
C4 Therapeutics to Participate in Upcoming September Investor Conferences
August 29, 2024
 · 
1 min read
Press Releases
C4 Therapeutics Announces European Society for Medical Oncology (ESMO) Changed the Previously Accepted CFT1946 Preliminary Phase 1 Abstract to a Proffered Paper Presentation
August 14, 2024
 · 
2 min read
Press Releases
C4 Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
August 1, 2024
 · 
10 min read
News
C4 Therapeutics to Present Preliminary Monotherapy Data from the Ongoing Phase 1 Trial of CFT1946 as a Mini Oral Presentation at the ESMO Congress 2024
July 16, 2024
 · 
2 min read
News
C4 Therapeutics to Participate in the Virtual UBS Targeted Protein Degradation Day
July 8, 2024
 · 
1 min read
Business
C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 8, 2024
 · 
12 min read
Genetown
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - April 29, 2024
April 29, 2024
 · 
1 min read
Load More